Between Gilead Sciences and Regeneron Pharmaceuticals, Which Stock Looks Set to Break Out?
Regeneron Pharmaceuticals surged 15% during the past Month. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Gilead Sciences gives you more. Gilead Sciences (GILD) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Regeneron Pharmaceuticals (REGN) stock, suggesting you may be better off investing in GILD
- GILD’s quarterly revenue growth was 3.0%, vs. REGN’s 0.9%.
- In addition, its Last 3-Year Average revenue growth came in at 2.3%, ahead of REGN’s 1.4%.
- GILD leads on profitability over both periods – LTM margin of 38.3% and 3-year average of 39.2%.
These differences become even clearer when you look at the financials side by side. The table highlights how REGN’s fundamentals stack up against those of GILD on growth, margins, momentum, and valuation multiples.
Valuation & Performance Overview
| REGN | GILD | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 21.7 | 13.5 | GILD |
| Revenue Growth | |||
| Last Quarter | 0.9% | 3.0% | GILD |
| Last 12 Months | 2.9% | 2.8% | REGN |
| Last 3 Year Average | 1.4% | 2.3% | GILD |
| Operating Margins | |||
| Last 12 Months | 26.7% | 38.3% | GILD |
| Last 3 Year Average | 30.0% | 39.2% | GILD |
| Momentum | |||
| Last 3 Year Return | 17.7% | 58.1% | GILD |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: REGN Revenue Comparison | GILD Revenue Comparison
See more margin details: REGN Operating Income Comparison | GILD Operating Income Comparison
- This Strategy Pays You 12% While Lining Up PYPL at Bargain Prices
- Why GE Aerospace Stock May Drop Soon
- GoDaddy Stock: Strong Cash Flow Poised for a Re-Rating?
- Does Exxon Mobil Stock Have More Upside?
- Has Uber Technologies Stock Quietly Become a Value Opportunity?
- Could Cash Machine NVR Stock Be Your Next Buy?
See detailed fundamentals on Buy or Sell GILD Stock and Buy or Sell REGN Stock. Below we compare market return and related metrics across years.
Historical Market Performance
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| REGN Return | 31% | 14% | 22% | -19% | 9% | 4% | 67% | ||
| GILD Return | 30% | 24% | -2% | 19% | 37% | -2% | 151% | <=== | |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 84% | ||
| Monthly Win Rates [3] | |||||||||
| REGN Win Rate | 67% | 50% | 58% | 50% | 50% | 100% | 62% | ||
| GILD Win Rate | 58% | 33% | 42% | 67% | 67% | 0% | 44% | ||
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | 71% | <=== | |
| Max Drawdowns [4] | |||||||||
| REGN Max Drawdown | -8% | -13% | -6% | -20% | -32% | -1% | -13% | ||
| GILD Max Drawdown | 0% | -20% | -12% | -21% | -3% | -4% | -10% | ||
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | 0% | -7% | <=== | |
[1] Cumulative total returns since the beginning of 2021
[2] 2026 data is for the year up to 1/9/2026 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read REGN Dip Buyer Analyses to see how the stock has fallen and recovered in the past.
Still not sure about REGN or GILD? Consider portfolio approach.
A Multi Asset Portfolio Gives You Safer Smarter Growth
Individual stocks can soar or tank but multi asset exposure steadies the ride. A spread out portfolio captures upside while limiting the damage from any one market.
The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices